Viatris (VTRS) Enterprise Value (2019 - 2026)

Viatris' (VTRS) quarterly Enterprise Value came in at -$1.8 billion in Q1 2026, down 138.97% year-on-year from $4.6 billion in Q1 2025, and down 36.43% quarter-over-quarter from -$1.3 billion in Q4 2025.

Viatris (VTRS) Enterprise Value (2019 - 2026) Analysis & Trends

Viatris' Enterprise Value history runs 8 years deep, the most recent figure standing at -$1.8 billion for Q1 2026.

  • On a quarterly basis, Enterprise Value fell 138.97% year-over-year to -$1.8 billion in Q1 2026; TTM through Mar 2026 was -$1.8 billion, a 138.97% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 billion, down 79.65% from the prior year.
  • Enterprise Value declined to -$1.8 billion in Q1 2026 per VTRS's latest filing, from -$1.3 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$506.6 million in Q1 2023 and bottomed at -$1.9 billion in Q3 2024.
  • The 5-year median for Enterprise Value is -$917.2 million (2024), against an average of -$984.3 million.
  • Across the five-year window, Enterprise Value surged 48.09% in 2025 and slumped 138.97% in 2026, its largest moves.
  • Year by year, Enterprise Value stood at -$1.3 billion in 2022, then increased by 21.43% to -$991.9 million in 2023, then gained by 25.79% to -$736.1 million in 2024, then tumbled by 79.65% to -$1.3 billion in 2025, then plunged by 36.43% to -$1.8 billion in 2026.
  • Per Business Quant, the three latest VTRS Enterprise Value figures stand at -$1.8 billion (Q1 2026), -$1.3 billion (Q4 2025), and -$975.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -1.86 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -3.74 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -1.94 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -4.05 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -2.15 Bn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -3.97 Mn
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -1.80 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn -1.32 Bn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -428.00 Mn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn -153.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.80 Bn
Dec 31, 2025 -1.32 Bn
Sep 30, 2025 -975.30 Mn
Jun 30, 2025 -566.40 Mn
Mar 31, 2025 -755.00 Mn
Dec 31, 2024 -736.10 Mn
Sep 30, 2024 -1.88 Bn
Jun 30, 2024 -917.20 Mn
Mar 31, 2024 -1.01 Bn
Dec 31, 2023 -991.90 Mn
Sep 30, 2023 -1.31 Bn
Jun 30, 2023 -629.20 Mn
Mar 31, 2023 -506.60 Mn
Dec 31, 2022 -1.26 Bn
Sep 30, 2022 -646.70 Mn
Jun 30, 2022 -664.70 Mn
Mar 31, 2022 -752.40 Mn
Dec 31, 2021 -706.20 Mn
Sep 30, 2021 -756.60 Mn
Jun 30, 2021 -673.90 Mn